AC-[3-ALKYLTHIOPROLINE(31)] AND AC-[4-ALKYLTHIOPROLINE(31)] CCK4 ANALOGS - SYNTHESIS AND IMPLICATIONS FOR THE CCK-B RECEPTOR-BOUND CONFORMATION

被引:76
作者
KOLODZIEJ, SA
NIKIFOROVICH, GV
SKEEAN, R
LIGNON, MF
MARTINEZ, J
MARSHALL, GR
机构
[1] WASHINGTON UNIV,SCH MED,DEPT MOLEC BIOL & PHARMACOL,ST LOUIS,MO 63110
[2] WASHINGTON UNIV,CTR MOLEC DESIGN,ST LOUIS,MO 63130
[3] WARNER LAMBERT PARKE DAVIS,PARKE DAVIS PHARMACEUT RES DIV,ANN ARBOR,MI 48105
[4] FAC PHARM MONTPELLIER,CNRS,URA 1845,F-34060 MONTPELLIER,FRANCE
关键词
D O I
10.1021/jm00001a019
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
It has been reported that substitution of the Met(31) residue in Boc-CCK4 (Boc-Trp(30)-Met(31)-Asp(32)Phe(33)-NH2, CCK33 numbering) by trans-3-propyl-L-proline yields a highly potent and selective CCK-B agonist. To further explore the structural requirements of the Met(31) side chain in the receptor-bound conformation of CCK4, we have synthesized several Ac-CCK4 analogs containing substitution of Met(31) by 3- and 4-(alkylthio)-substituted proline derivatives. To this end we have developed novel synthetic routes to enantiomerically pure N-Boc-4-cis- and -trans-(methylthio)prolines and racemic N-Boc-3-cis and -trans-[(4-methylbenzyl)thio]prolines. The protected mercaptoprolines were incorporated into Ac-CCK4 analogs using SPPS and were alkylated using various electrophiles following cleavage from the solid support. Binding assays reveal that 3-(alkylthio)prolines analogs have higher affinities at the CCK-B receptor than the corresponding 4-(alkylthio)proline analogs, and that trans-3-(alkylthio)proline analogs had higher affinities than corresponding cis-3-(alkylthio)proline analogs. Within both the cis- and trans-3-(alkylthio)proline series, the order of potency was found to be Me < Et < n-Pr. The trans-3-(n-propylthio)-L-proline analog demonstrates a higher affinity than that reported for Boc-CCK4[trans-3-propyl-L-Pro(31)]. Comparison of the low-energy structures calculated for several high-affinity Ac-CCK4 analogs reveal a common geometry which we propose to be the CCK-B receptor-bound conformation. This model shows grouping ofthe hydrophobic side chains of Trp, Met, and Phe at one side of the molecule and the hydrophilic side chain of Asp and the C-terminal carboxamide at the other side.
引用
收藏
页码:137 / 149
页数:13
相关论文
共 40 条
[1]  
BODANSZKY M, 1980, J MED CHEM, V33, P82
[2]  
BODANSZKY M, 1984, PRACTICE PEPTIDE SYN, P12
[3]   CCK-B AGONIST OR ANTAGONIST ACTIVITIES OF STRUCTURALLY HINDERED AND PEPTIDASE-RESISTANT BOC-CCK4 DERIVATIVES [J].
CORRINGER, PJ ;
WENG, JH ;
DUCOS, B ;
DURIEUX, C ;
BOUDEAU, P ;
BOHME, A ;
ROQUES, BP .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (01) :166-172
[4]   CLASSIFICATION AND FUNCTION OF CCK RECEPTORS [J].
DOURISH, CT ;
HILL, DR .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1987, 8 (06) :207-208
[5]   ENERGY PARAMETERS IN POLYPEPTIDES .8. EMPIRICAL POTENTIAL-ENERGY ALGORITHM FOR CONFORMATIONAL-ANALYSIS OF LARGE MOLECULES [J].
DUNFIELD, LG ;
BURGESS, AW ;
SCHERAGA, HA .
JOURNAL OF PHYSICAL CHEMISTRY, 1978, 82 (24) :2609-2616
[6]   SYNTHESIS AND BIOLOGICAL-ACTIVITIES OF NEW PENEM DERIVATIVES WITH SIDE-CHAINS DERIVED FROM 4-HYDROXYPROLINE [J].
EMMER, G ;
KNEUSSEL, P ;
HILDEBRANDT, J ;
TURNOWSKY, F ;
HASELBERGER, A ;
WENZEL, A ;
STUTZ, P .
JOURNAL OF ANTIBIOTICS, 1985, 38 (10) :1371-1386
[7]   CONFORMATIONAL-ANALYSIS AND STRUCTURAL ACTIVITY RELATIONSHIPS OF CHOLECYSTOKININ PEPTIDES [J].
FOURNIEZALUSKI, MC ;
BELLENEY, J ;
DURIEUX, C ;
GACEL, G ;
ROQUES, BP ;
BEGUE, D ;
MENANT, I ;
LUX, B ;
GERARD, D .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1985, 448 (JUL) :598-600
[8]   CONFORMATIONAL-ANALYSIS OF CHOLECYSTOKININ CCK26-33 AND RELATED FRAGMENTS BY H-1-NMR SPECTROSCOPY, FLUORESCENCE-TRANSFER MEASUREMENTS, AND CALCULATIONS [J].
FOURNIEZALUSKI, MC ;
BELLENEY, J ;
LUX, B ;
DURIEUX, C ;
GERARD, D ;
GACEL, G ;
MAIGRET, B ;
ROQUES, BP .
BIOCHEMISTRY, 1986, 25 (13) :3778-3787
[9]   CONFORMATIONAL-ANALYSIS OF CCK-B AGONISTS USING H-1-NMR AND RESTRAINED MOLECULAR-DYNAMICS - COMPARISON OF BIOLOGICALLY-ACTIVE BOC-TRP-(N-ME)NLE-ASP-PHE-NH2 AND INACTIVE BOC-TRP-(N-ME)PHE-ASP-PHE-NH2 [J].
GOUDREAU, N ;
WENG, JH ;
ROQUES, BP .
BIOPOLYMERS, 1994, 34 (02) :155-169
[10]  
HAUSLER J, 1979, LIEBIGS ANN CHEM, P1881